te Pharmaceuticals: Today Latest News, Photos, Videos about Pharmaceuticals - Zee Business

हिंदी में पढ़ें

Pharmaceuticals

India Resurgence Fund to acquire API and CRAMS business of Ind-Swift Laboratories for Rs 1,650 crore

India Resurgence Fund to acquire API and CRAMS business of Ind-Swift Laboratories for Rs 1,650 crore

Wed, Sep 06, 2023

India's Ind-Swift Laboratories to sell its API and CRAMS business to Synthimed Labs, a portfolio company of India Resurgence Fund (IndiaRF).

USFDA issues warning letter to Intas Pharma for Sanand plant

USFDA issues warning letter to Intas Pharma for Sanand plant

Sun, Aug 06, 2023

The US health regulator also pointed out the company's failure to ensure that laboratory records included complete data derived from all tests necessary to ensure compliance with established specifications and standards.

IPCA Labs drops nearly 3% after USFDA concludes inspection of Madhya Pradesh unit with 11 observations

IPCA Labs drops nearly 3% after USFDA concludes inspection of Madhya Pradesh unit with 11 observations

Wed, Jun 14, 2023

The inspection of the Ratlam facility was conducted from June 5 to June 13, 2023. The Ratlam facility of IPCA Labs was under an import alert since FY15, resulting in a halt in its supplies to the United States.

TRENDING NOW

Three new schemes for pharma sector MSMEs launched; Details

Three new schemes for pharma sector MSMEs launched; Details

Thu, Jul 21, 2022

Mandaviya asked the industry to keep upgrading in order to cater to evolving requirements across global markets.

HCL Technologies signs multi-year IT deal with personal care brand DSM

Mon, Jul 18, 2022

Through harnessing automation and analytics, HCL plans to enhance IT service delivery for approximately 18,000 end users across 200 sites in more than 50 countries for DSM.

Pharma company Innova Captab files IPO papers with Sebi

Pharma company Innova Captab files IPO papers with Sebi

Wed, Jun 29, 2022

Innova Captab is an integrated pharmaceutical company.

Lupin gets tentative USFDA nod for generic Azilsartan Medoxomil tablets to treat high BP

Lupin gets tentative USFDA nod for generic Azilsartan Medoxomil tablets to treat high BP

Fri, Dec 24, 2021

Homegrown pharmaceuticals major Lupin on Friday said it has received tentative approval from the US health regulator for its generic Azilsartan Medoxomil tablets used to treat high blood pressure.

Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk

Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk

Fri, Jan 01, 2021

Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors

Exclusive: Piramal Enterprises to sell 15-20 pct stake in pharma biz, sources say

Exclusive: Piramal Enterprises to sell 15-20 pct stake in pharma biz, sources say

Tue, Jun 23, 2020

In a major development, Piramal Enterprises Limited (PEL) is planning to unlock its pharma business by selling 15-20 per cent in the business. The company is planning to raise Rs 3500- Rs 4500 cr through the stake sale. Zee Business Executive Editor Swati Khandelwal has an exclusive report on this

Jubilant Cadista recalls 12,960 bottles of erosive esophagitis tablets

Jubilant Cadista recalls 12,960 bottles of erosive esophagitis tablets

Sun, Apr 14, 2019

Jubilant Cadista Pharmaceuticals Inc is recalling 12,960 bottles of the tablets in the strength of 40 mg, manufactured by Jubilant Generics Ltd at its Roorkee plant, the Enforcement Report of the US Food and Drug Adminstration (USFDA) said.

Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Fri, Oct 19, 2018

Jubilant Cadista Pharmaceuticals Inc, is recalling over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets manufactured by Jubilant Generics Ltd at its Roorkee plant, from the America and Puerto Rico market, latest report of the US health regulator has said.

Revenue growth to hit 5-year high in Q3: CRISIL Research

Revenue growth to hit 5-year high in Q3: CRISIL Research

Wed, Jan 10, 2018

Key highlights:

Govt allows 100% FDI under automatic route for single brand retail

Wed, Jan 10, 2018

Union Cabinet today approved 100 per cent Foreign Direct Investment (FDI) under automatic route for single brand retail trading. Upto 49 per cent FDI is allowed under automatic route presently, but any investment beyond the limit requires government approval.

Biocon arm widens partnership terms with Bristol-Myers Squibb

Biocon arm widens partnership terms with Bristol-Myers Squibb

Tue, Nov 14, 2017

Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026.

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Fri, Jul 28, 2017

Key Highlights 7 drugs represent a total estimated market potential of more than $800 million

Investor in Martin Shkreli's fund says he made millions

Investor in Martin Shkreli's fund says he made millions

Thu, Jul 06, 2017

One of the investors former drug company executive Martin Shkreli is accused of defrauding testified on Wednesday that Shkreli lied to him repeatedly, although he eventually made millions of dollars from the investment.

A final check: How GST impacts your toothpaste to your car purchase

A final check: How GST impacts your toothpaste to your car purchase

Fri, Jun 30, 2017

With the GST rollout at the stroke of midnight tonight here is how it will impact your business, industry and even your household finances.

Sun Pharma shares touch new lows as pricing pressure in US continues

Sun Pharma shares touch new lows as pricing pressure in US continues

Mon, May 29, 2017

Sun Pharma's fourth quarter results have been disappointing. The company said that pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.

Dr Reddy's Q4 net profit rises by 319%

Dr Reddy's Q4 net profit rises by 319%

Fri, May 12, 2017

GV Prasad, Co-Chairman and CEO of Dr Reddy's Laboratories said, “FY17 has been challenging year due to lack of new product approvals for the US market. However, our other geoghraphies delivered good performance with several new product launches.”

56% disapprove of Republican health care bill: Poll

56% disapprove of Republican health care bill: Poll

Fri, Mar 24, 2017

"Replacing Obamacare will come with a price for elected representatives who vote to scrap it, say many Americans, who clearly feel their health is in peril under the Republican alternative," CNN quoted Tim Malloy, assistant director of the poll, as saying.

Glenmark receives tentative approval Fingolimod Capsules; shares down

Glenmark receives tentative approval Fingolimod Capsules; shares down

Mon, Mar 20, 2017

Glenmark’s current portfolio consists of 112 products authorized for distribution in the US marketplace.

Sun Pharma shares rise as USFDA clears Mohali facility

Sun Pharma shares rise as USFDA clears Mohali facility

Tue, Mar 14, 2017

Sun Pharma said, “It's subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status."

Lupin launches pain relief drug in US; shares rise

Lupin launches pain relief drug in US; shares rise

Thu, Mar 09, 2017

Drug firm Lupin today announced the launch of pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x